Eur Respir J 2001; 17:1112-1119
Copyright ©ERS Journals Ltd 2001
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
S. Gompertz,
C. O'Brien,
D.L. Bayley,
S.L. Hill and
R.A. Stockley
Dept of Respiratory Medicine, Queen Elizabeth Hospital, Birmingham, UK
CORRESPONDENCE: S. Gompertz, Dept of Respiratory Medicine, First Floor, Nuffield House Q. E. Hospital, Edgbaston, Birmingham, B15 2TH, UK
Keywords: bronchitis, chronic bronchitis, exacerbations, inflammation
Received: December 31, 1999
Accepted January 8, 2001
This work was supported by an unrestricted educational grant from GlaxoSmith-Kline.
There are little data describing noncellular changes in bronchial inflammation during exacerbations of chronic bronchitis. The relationship between sputum colour and airway inflammation at presentation has been assessed during an exacerbation in patients with chronic bronchitis and a primary care diagnosis of chronic obstructive pulmonary disease.
Sputum myeloperoxidase, neutrophil elastase, leukotriene B4 (LTB4), interleukin-8 (IL-8), sol:serum albumin ratio and serum C-reactive protein were measured in patients presenting with an exacerbation and mucoid (n=27) or purulent sputum (n=42).
Mucoid exacerbations were associated with little bronchial or systemic inflammation at presentation, and sputum bacteriology was similar to that obtained in the stable state. Purulent exacerbations were associated with marked bronchial and systemic inflammation (p<0.025 for all features) and positive sputum cultures (90%). Resolution was related to a significant reduction in LTB4 (p<0.01), but no change in IL-8, suggesting that LTB4 may be more important in neutrophil recruitment in these mild, purulent exacerbations. In the stable state, IL-8 remained higher in patients who had experienced a purulent exacerbation (2p<0.02).
The presented results indicate that exacerbations of chronic bronchitis, defined by sputum colour, differ in the degree of bronchial and systemic inflammation. Purulent exacerbations are related to bacterial infection, and are associated with increased neutrophilic inflammation and increased leukotriene B4 concentrations.
This article has been cited by other articles:

|
 |

|
 |
 
A Di Stefano, G Caramori, I Gnemmi, M Contoli, L Bristot, A Capelli, F L M Ricciardolo, F Magno, S E. D'Anna, A Zanini, et al.
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD
Thorax,
November 1, 2009;
64(11):
968 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anzueto and M. Miravitlles
Efficacy of tiotropium in the prevention of exacerbations of COPD
Therapeutic Advances in Respiratory Disease,
June 1, 2009;
3(3):
103 - 111.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
November 27, 2008;
359(22):
2355 - 2365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B M Roede, P Bresser, P J E Bindels, A Kok, M Prins, G t. Riet, R B Geskus, R M C Herings, and J M Prins
Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study
Thorax,
November 1, 2008;
63(11):
968 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Holme, J. W. Tomlinson, R. A. Stockley, P. M. Stewart, N. Barlow, and A. L. Sullivan
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids
Eur. Respir. J.,
October 1, 2008;
32(4):
1047 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. McManus, A-M. Marley, N. Baxter, S. N. Christie, J. S. Elborn, H. J. O'Neill, P. V. Coyle, and J. C. Kidney
High levels of Epstein-Barr virus in COPD
Eur. Respir. J.,
June 1, 2008;
31(6):
1221 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Newcomb, U. S. Sajjan, D. R. Nagarkar, Q. Wang, S. Nanua, Y. Zhou, C. L. McHenry, K. T. Hennrick, W. C. Tsai, J. K. Bentley, et al.
Human Rhinovirus 1B Exposure Induces Phosphatidylinositol 3-Kinase-dependent Airway Inflammation in Mice
Am. J. Respir. Crit. Care Med.,
May 15, 2008;
177(10):
1111 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kim, T. J. Rogers, and G. J. Criner
New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
478 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Bayley, H. Abusriwil, A. Ahmad, and R. A. Stockley
Validation of assays for inflammatory mediators in exhaled breath condensate
Eur. Respir. J.,
May 1, 2008;
31(5):
943 - 948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Bacterial Load and Exacerbations of COPD
Am. J. Respir. Crit. Care Med.,
May 1, 2008;
177(9):
1049 - 1049.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abusriwil and R. A. Stockley
Bacterial Load and Exacerbations of COPD
Am. J. Respir. Crit. Care Med.,
May 1, 2008;
177(9):
1048 - 1049.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
820 - 829.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Murphy, A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
853 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T. F. Murphy
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Chung, A. Toriba, H. Y. Chung, B. P. Yu, T. Kameda, N. Tang, R. Kizu, and K. Hayakawa
Activation of 5-Lipoxygenase and NF-{kappa}B in the Action of Acenaphthenequinone by Modulation of Oxidative Stress
Toxicol. Sci.,
January 1, 2008;
101(1):
152 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Eur. Respir. J.,
December 1, 2007;
30(6):
1043 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abusriwil and R. A. Stockley
The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage
Proceedings of the ATS,
December 1, 2007;
4(8):
611 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sykes, P. Mallia, and S. L. Johnston
Diagnosis of Pathogens in Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 1, 2007;
4(8):
642 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles
Review: Do we need new antibiotics for treating exacerbations of COPD?
Therapeutic Advances in Respiratory Disease,
October 1, 2007;
1(1):
61 - 76.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anzueto, S. Sethi, and F. J. Martinez
Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
554 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Newcomb, U. S. Sajjan, D. R. Nagarkar, A. M. Goldsmith, J. K. Bentley, and M. B. Hershenson
Cooperative effects of rhinovirus and TNF-{alpha} on airway epithelial cell chemokine expression
Am J Physiol Lung Cell Mol Physiol,
October 1, 2007;
293(4):
L1021 - L1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B. J. B. Grant, and T. F. Murphy
Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 15, 2007;
176(4):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev,
July 1, 2007;
87(3):
1047 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J.,
June 1, 2007;
29(6):
1224 - 1238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Cote, L. J. Dordelly, and B. R. Celli
Impact of COPD Exacerbations on Patient-Centered Outcomes
Chest,
March 1, 2007;
131(3):
696 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, R. J. Sapsford, H. Mullerova, G. C. Donaldson, and J. A. Wedzicha
Inflammatory changes, recovery and recurrence at COPD exacerbation
Eur. Respir. J.,
March 1, 2007;
29(3):
527 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Bentley, D. C. Newcomb, A. M. Goldsmith, Y. Jia, U. S. Sajjan, and M. B. Hershenson
Rhinovirus Activates Interleukin-8 Expression via a Src/p110{beta} Phosphatidylinositol 3-Kinase/Akt Pathway in Human Airway Epithelial Cells
J. Virol.,
February 1, 2007;
81(3):
1186 - 1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, C. Muller, P. Huber, B. Muller, and M. Tamm
Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy
Chest,
January 1, 2007;
131(1):
9 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest,
January 1, 2007;
131(1):
37 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roghanian, E. M. Drost, W. MacNee, S. E. M. Howie, and J.-M. Sallenave
Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase
Am. J. Respir. Crit. Care Med.,
December 1, 2006;
174(11):
1189 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
October 15, 2006;
174(8):
867 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mallia and S. L. Johnston
How viral infections cause exacerbation of airway diseases.
Chest,
October 1, 2006;
130(4):
1203 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. S. Sajjan, Y. Jia, D. C. Newcomb, J. K. Bentley, N. W. Lukacs, J. J. LiPuma, and M. B. Hershenson
H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression
FASEB J,
October 1, 2006;
20(12):
2121 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papi, C. M. Bellettato, F. Braccioni, M. Romagnoli, P. Casolari, G. Caramori, L. M. Fabbri, and S. L. Johnston
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1114 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papi, F. Luppi, F. Franco, and L. M. Fabbri
Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2006;
3(3):
245 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vestbo
Clinical Assessment, Staging, and Epidemiology of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
May 1, 2006;
3(3):
252 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Sapey and R A Stockley
COPD exacerbations {middle dot} 2: Aetiology.
Thorax,
March 1, 2006;
61(3):
250 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, and J. A. Wedzicha
Systemic and Upper and Lower Airway Inflammation at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
71 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Newcomb, U. Sajjan, S. Nanua, Y. Jia, A. M. Goldsmith, J. K. Bentley, and M. B. Hershenson
Phosphatidylinositol 3-Kinase Is Required for Rhinovirus-induced Airway Epithelial Cell Interleukin-8 Expression
J. Biol. Chem.,
November 4, 2005;
280(44):
36952 - 36961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
November 1, 2005;
2(4):
361 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Montuschi, F Macagno, P Parente, S Valente, L Lauriola, G Ciappi, S A Kharitonov, P J Barnes, and G Ciabattoni
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD
Thorax,
October 1, 2005;
60(10):
827 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Brock, Y.-J. Lee, E. Maydanski, T. L. Marburger, M. Luo, R. Paine III, and M. Peters-Golden
Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung
Am J Physiol Lung Cell Mol Physiol,
August 1, 2005;
289(2):
L224 - L232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J.,
June 1, 2005;
25(6):
1084 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas
Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD
Chest,
June 1, 2005;
127(6):
1911 - 1918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides
Leukotriene B4 in Exhaled Breath Condensate and Sputum Supernatant in Patients With COPD and Asthma
Chest,
May 1, 2005;
127(5):
1553 - 1559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rosell, E. Monso, N. Soler, F. Torres, J. Angrill, G. Riise, R. Zalacain, J. Morera, and A. Torres
Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease
Arch Intern Med,
April 25, 2005;
165(8):
891 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujimoto, M. Yasuo, K. Urushibata, M. Hanaoka, T. Koizumi, and K. Kubo
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Eur. Respir. J.,
April 1, 2005;
25(4):
640 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev.,
December 1, 2004;
56(4):
515 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Pauwels
Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
April 1, 2004;
1(2):
73 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi
Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease: Phenomenon or Epiphenomenon?
Proceedings of the ATS,
April 1, 2004;
1(2):
109 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J.,
October 1, 2003;
22(4):
672 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ahmad, D. L. Bayley, S. He, and R. A. Stockley
Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
October 1, 2003;
29(4):
523 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Agusti, W MacNee, K Donaldson, and M Cosio
Hypothesis: Does COPD have an autoimmune component?
Thorax,
October 1, 2003;
58(10):
832 - 834.
[Full Text]
|
 |
|

|
 |

|
 |
 
A J White, S Gompertz, D L Bayley, S L Hill, C O'Brien, I Unsal, and R A Stockley
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis
Thorax,
August 1, 2003;
58(8):
680 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J.,
June 1, 2003;
21(41_suppl):
19S - 28s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W A Biernacki, S A Kharitonov, and P J Barnes
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD
Thorax,
April 1, 2003;
58(4):
294 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A J White, S Gompertz, and R A Stockley
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
Thorax,
January 1, 2003;
58(1):
73 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gompertz and R. A. Stockley
A Randomized, Placebo-Controlled Trial of a Leukotriene Synthesis Inhibitor in Patients With COPD*
Chest,
July 1, 2002;
122(1):
289 - 294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Eur. Respir. J.,
July 1, 2002;
20(36_suppl):
9S - 19s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sohy, C. Pilette, M.S. Niederman, and Y. Sibille
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Eur. Respir. J.,
May 1, 2002;
19(5):
966 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Stockley
Neutrophils and the Pathogenesis of COPD*
Chest,
May 1, 2002;
121
(2009):
151S - 155S.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the European Respiratory Society.
|